Knockout/Knockdown Validation: GeneTex Incorporates Negative Controls into the Quality Assurance Process

GeneTex is conducting knockout/knockdown-based validation as a fundamental component of its antibody quality assurance process. To date, over four hundred of their most popular products have been evaluated, covering multiple research topics, such as apoptosis, metabolism, epithelial–mesenchymal transition, and neurodegenerative diseases. They seek to continue to expand these efforts in the future. Antibodies that have passed the KO/KD test will be labeled with the KO/KD validated icon.